Dr. John Day of Stanford University presents an overview of brain-related DM impacts that can affect sleep, and current thinking regarding strategies to manage this very prevalent DM symptom. From the 2017 MDF Annual Conference.
Drs. Laurence Mignon, Ph.D., director of clinical development at Ionis Pharmaceuticals, and Michael Horrigan, M.D., chief medical officer at AMO Pharma, present updates on the status of Phase I/II clinical trials current underway at their industry institutions for potential DM1 therapies – at the 2016 MDF Annual Conference.
Drs. John Day, M.D., Ph.D, of Stanford University, Chad Heatwole, M.D., of the University of Rochester and Giovanni Meola, M.D., of the University of Milan present an overview of DM-related disease impacts and symptoms, and the current status of brain-related DM research – at the 2016 MDF Annual Conference.
Mid-Year Legislative Webinar that includes an update on DM research funding requests to the NIH & DoD research programs, information on what Congress is likely to do next, and facts to help you advocate for DM funding.
MDF Fellows report on the current status of their research findings. Featuring: Dr. Ranjan Batra, PhD, University of California San Diego; Dr. Viachaslau Bernat, PhD, Scripps Research Institute Florida; Dr. Melissa Hinman, PhD, University of Oregon; and Dr. Ravi Kanth Rao Saini, PhD, Scripps Research Institute La Jolla.